European Journal of Radiology
Volume 73, Issue 2 , Pages 215-220 , February 2010

Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting

  • Gisele B. Caseiras

      Affiliations

    • Institute of Neurology, UCL, London SW1X 0HZ, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 7810447422; fax: +44 2072785616.
    • ,
  • Sophie Chheang

      Affiliations

    • Department of Radiology, New York University Medical Center, New York, NY, USA
    • ,
  • James Babb

      Affiliations

    • Department of Radiology, New York University Medical Center, New York, NY, USA
    • ,
  • Jeremy H. Rees

      Affiliations

    • Institute of Neurology, UCL, London SW1X 0HZ, UK
    • ,
  • Nicole Pecerrelli

      Affiliations

    • Department of Radiology, New York University Medical Center, New York, NY, USA
    • ,
  • Daniel J. Tozer

      Affiliations

    • Institute of Neurology, UCL, London SW1X 0HZ, UK
    • ,
  • Christopher Benton

      Affiliations

    • Institute of Neurology, UCL, London SW1X 0HZ, UK
    • ,
  • David Zagzag

      Affiliations

    • Department of Pathology and Neurosurgery, New York University Medical Center, New York, NY, USA
    • ,
  • Glyn Johnson

      Affiliations

    • Department of Radiology, New York University Medical Center, New York, NY, USA
    • ,
  • Adam D. Waldman

      Affiliations

    • Institute of Neurology, UCL, London SW1X 0HZ, UK
    • Imperial College of Science Technology and Medicine, London, UK
    • ,
  • H.R. Jäger

      Affiliations

    • Institute of Neurology, UCL, London SW1X 0HZ, UK
    • ,
  • Meng Law

      Affiliations

    • Department of Radiology and Neurosurgery, Mount Sinai Medical Center, New York, NY, USA

Received 25 July 2008 ,Revised 8 November 2008 ,Accepted 10 November 2008.

References 

  1. McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, Ransohoff J. Treatment and survival of low-grade astrocytoma in adults—1977–1988. Neurosurgery. 1992;31:636–642discussion 642
  2. Olson JD, Riedel E, DeAngelis LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology. 2000;54:1442–1448
  3. Johannesen T, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumours were diagnosed between 1970 and 1993. J Neurosurg. 2003;854–862
  4. van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005;366:985–990
  5. Bauman G, Pahapill P, Macdonald P, Fisher B, Leighton C, Cairncross G. Low grade glioma: a measuring radiographic response to radiotherapy. Can J Neurol Sci. 1999;26:18–22
  6. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20:2076–2084
  7. Medbery CA, Straus KL, Steinberg SM, Cotelingam JD, Fisher WS. Low-grade astrocytomas: treatment results and prognostic variables. Int J Radiat Oncol Biol Phys. 1988;15:837–841
  8. Gilles FH, Brown WD, Leviton A, et al. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium. Cancer. 2000;88:1477–1483
  9. Prayson RA, Mohan DS, Song P, Suh JH. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas. Ann Diagn Pathol. 2000;4:218–227
  10. Coons SW, Johnson PC, Pearl DK. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery. 1997;41:878–884discussion 875–884
  11. Law M, Oh S, Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging—prediction of patient clinical response. Radiology. 2006;238:658–667
  12. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med. 1990;14:249–265
  13. Rosen BR, Belliveau JW, Buchbinder BB, et al. Contrast agents and cerebral hemodynamics. Magn Reson Med. 1991;19:285–292
  14. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology. 2002;224:797–803
  15. Brasil Caseiras G, Thornton JS, Yousry T, et al. Inclusion or exclusion of intratumoral vessels in relative cerebral blood volume characterization in low-grade gliomas: does it make a difference?. Am J Neuroradiol. 2008;29:1140–1141
  16. Levin VA, Hess KR, Choucair A, et al. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine–PCV versus PCV for anaplastic gliomas. Clin Cancer Res. 2003;9:981–990
  17. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol. 2003;24:1989–1998
  18. Law M, Oh S, Johnson G, et al. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery. 2006;58:1099–1107discussion 1099-107
  19. Law M, Young RJ, Babb JS, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2008;247:490–498
  20. Aronen HJ, Gazit IA, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumour grade and histologic findings. Radiology. 1994;191:41–45
  21. Tzika AA, Astrakas LG, Zarifi MK, et al. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer. 2004;100:1246–1256
  22. Danchaivijitr N, Waldman AD, Tozer DJ, et al. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?. Radiology. 2008;247:170–178
  23. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. Am J Neuroradiol. 2004;25:214–221
  24. Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997;15:1294–1301
  25. Sugahara T, Korogi Y, Kochi M, Ushio Y, Takahashi M. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. Am J Neuroradiol. 2001;22:1306–1315
  26. Maia AC, Malheiros SM, da Rocha AJ, et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. Am J Neuroradiol. 2005;26:777–783

PII: S0720-048X(08)00629-3

doi: 10.1016/j.ejrad.2008.11.005

European Journal of Radiology
Volume 73, Issue 2 , Pages 215-220 , February 2010

Article Tools

* Image Usage & Resolution